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     BSTRACT
Anthelmintic resistance of parasites in small ruminants, cattle and horses is increasing worldwide 
as a consequence of the over usage of the currently available products. In Belgium, Cooperia 
oncophora is the most common cattle nematode in which resistance, especially against macrocyclic 
lactones, occurs. Once resistance has been diagnosed, a change to another drug with a different 
mode of action is advised. However, effective anthelmintics will be hardly available in the near 
future. Therefore, it is important that farmers and veterinarians fi nd a balance between achieving 
good parasite control and the sustainability of their control strategies. In this way, anthelmintic 
resistance may be delayed, and the effectiveness of anthelmintic drugs may be prolonged. This 
requires sensitive detection tools. With a sensitive detection technique, anthelmintic resistance can 
be diagnosed in a very early stage. Hence, the spread of resistance alleles in the parasite population 
may be prevented. In this review, different diagnostic assays for the detection of anthelmintic 
resistance are discussed, an overview is given of the current status of anthelmintic resistance in 
Belgian cattle, and measures are suggested to avoid or delay the development of anthelmintic 
resistance. 
SAMENVATTING
Anthelminthicumresistentie van parasieten bij kleine herkauwers, runderen en paarden wordt wereld-
wijd steeds groter als gevolg van een overmatig gebruik van de beschikbare ontwormingsproducten. In 
België is Cooperia oncophora de meest voorkomende rundernematode waarbij resistentie wordt vastge-
steld; voorlopig enkel tegen macrocyclische lactonen. Eens resistentie is vastgesteld, kan het nodig zijn om 
over te schakelen naar een product met een ander werkingsmechanisme. Er zijn echter bijna geen nieuwe 
doeltreffende ontwormingsproducten meer beschikbaar. Het is daarom belangrijk dat landbouwers en 
dierenartsen een evenwicht vinden om zowel worminfecties onder controle te krijgen als de duurzaamheid 
van hun behandelingsstrategie te garanderen. Op deze manier kan de ontwikkeling van anthelminthicum-
resistentie vertraagd worden en de doeltreffendheid van de beschikbare anthelminthica verlengd worden. 
Dit vereist natuurlijk een gevoelige detectietechniek om resistentie op te sporen. Aan de hand van een 
gevoelige detectietechniek kan de diagnose van anthelminthicumresistentie reeds in een vroeg stadium 
gesteld worden en kan de verspreiding van resistentieallelen in de wormpopulatie tegengehouden of ver-
traagd worden. In dit artikel worden de beschikbare tests voor de detectie van anthelminthicumresistentie 
besproken. Er wordt een stand van zaken gegeven van anthelminthicumresistentie bij runderen in België 
en er worden maatregelen voorgesteld om resistentie te vermijden of te vertragen.
A
INTRODUCTION TO ANTHELMINTIC
RESISTANCE
Worldwide, infections with parasitic nematodes 
restrict the welfare and productivity of livestock. 
The control of these parasites relies heavily on the 
administration of anthelmintic drugs. Between 1960 
and 1990, the pharmaceutical industry made major 
progress in developing deworming compounds with 
excellent broad-spectrum activity and safety (McKel-
lar and Jackson, 2004). This led to the discovery of 
three major drug classes available for ruminants, each 
with distinct modes of action: benzimidazoles (BZs), 
imidothiazoles and tetrahydropyrimidines (I/Ts) and 
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Anthelmintic Mode of action Generic drug Introduced Resistance Reference
drug class  name on the reported
   market
Heterocyclic Blocking dopaminergic Phenothiazine 1940 1957 (Leland et al., 1957)
compounds transmission
 Agonist of the inhibitory Piperazine 1954 1966 (Drudge et al., 1988)
 GABA-receptor
Benzimidazoles Inhibiting polymerisation Thiabendazole 1961 1964 (Drudge et al., 1964)
 of microtubules
  Cambendazole 1970 1975 (Berger, 1975)
  Oxibendazole 1970 1985 (Drudge et al., 1985)
  Mebendazole 1972 1975 (Berger, 1975)
  Albendazole 1972 1983 (Cawthorne and
     Whitehead, 1983)
  Fenbendazole 1975 1982 (Boersema and Lewing-
     van der Wiel, 1982)
  Oxfendazole 1976 1981 (Le Jambre et al., 1981)
  Triclabendazole 1983 1998 (Mitchell et al., 1998)
Imidazothiazoles and Agonist of nicotinergic Levamisole 1970 1979 (Sangster et al., 1979)
Tetrahydopyrimidines acetylcholine receptors Pyrantel 1974 1996 (Chapman et al., 1996)
  Oxantel 1976 - -
  Morantel 1970 1979 (Sangster et al., 1979)
Macrocyclic lactones Allosteric modulators of the Abamectin Late 1970’s 2001 (Wooster et al., 2001)
 glutamate-gated chloride
 channels
  Ivermectin 1981 1988 (van Wyk and Malan, 1988)
  Moxidectin 1991 1995 (Leathwick, 1995)
  Doramectin 1993 2007 (Borgsteede et al., 2007)
  Eprinomectn 1996 2003 (Loveridge et al., 2003)
Amino-acetonitrile Agonist of nicotinergic Monepantel 2009 - -
derivative acetylcholine receptors
Spiroindole Antagonist of cation channels Derquantel 2010 - -
Table 1. Introduction of anthelmintic drugs for ruminants and the development of resistance to the drug.
macrocyclic lactones (MLs). Relatively shortly after 
their introduction into the market, the development 
of resistance against all anthelmintic drug classes has 
been reported (Table 1).
Anthelmintic resistance occurs when parasites, 
usually eliminated by a given dose, suddenly sur-
vive the treatment. Since resistance is inherited, the 
surviving worms will pass their resistance alleles to 
their progeny (Sangster, 1999). Resistance against 
drugs belonging to the same anthelmintic drug class 
is called side-resistance, whereas cross- and multi-
drug-resistance refers to resistance against two or 
multiple drugs belonging to different anthelmintic 
drug classes. Today, the problem of anthelmintic re-
sistance is by far the most severe in small ruminants. 
Multidrug resistance of the major gastrointestinal 
nematodes has been documented worldwide in sheep 
and goats (e.g. Haemonchus contortus, Teladorsagia 
circumcincta, Trichostrongylus spp. and Cooperia 
spp.) (Van Wyk et al., 1999; Chandrawathani et al., 
2003; McKenna, 2010; Sargison et al., 2010; Kaplan 
and Vidyashankar, 2012; Torres-Acosta et al., 2012). 
In South Africa, New Zealand and Australia, multi-
drug resistance has even forced a few farmers to stop 
sheep and goat farming (Kaplan, 2004; Geary, 2005).
Compared to small ruminants, few fi eld surveys 
have been performed to investigate the prevalence 
of anthelmintic resistance of cattle parasites. There-
fore, the number of cases of cattle nematodes re-
sistant to anthelmintic drugs might be considerably 
underestimated. Resistance against I/Ts or BZs has 
been reported in most of the major gastrointestinal 
nematodes in cattle (e.g. Cooperia spp., Haemonchus
placei, Ostertagia ostertagi and Trichostrongylus 
spp.). The prevalence of ML-resistance in cattle nema-
todes, especially Cooperia spp., is emerging in New 
Zealand, Argentina, Brazil, the USA and Northern 
Europe, including Belgium (Vermunt et al., 1996; 
Coles et al., 1998; Coles et al., 2001; Loveridge et al., 
2003; Mejia et al., 2003; Anziani et al., 2004; Mason 
and McKay, 2006; Waghorn et al., 2006; Soutello et 
al., 2007; Suarez and Cristel, 2007; Demeler et al., 
2009; Gasbarre et al., 2009; Edmonds et al., 2010; 
El-Abdellati et al., 2010a; El-Abdellati et al., 2010b).
Table 2 summarizes the results of the few fi eld sur-
veys that were conducted in order to assign the ex-
tent of anthelmintic resistance of bovine nematodes. 
Most alarming are the reports of multidrug resistance 
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against both MLs and BZs in New Zealand and South 
America (Waghorn et al., 2006; Soutello et al., 2007; 
Suarez and Cristel, 2007).
In this review, a summary is given of the princi-
pal contributors to the development of anthelmintic 
resistance and the detection methods to evaluate the 
effi cacy of MLs against ruminant nematodes. Subse-
quently, the most recent fi ndings about the resistance 
status of nematode species in cattle in Belgium are 
described. Finally, potential measures to delay the 
development of resistance are discussed.
FACTORS AFFECTING ANTHELMINTIC
RESISTANCE DEVELOPMENT
The development rate of anthelmintic resistance 
appears to be slow at fi rst, but once a certain level of 
resistance genes has been established, the following 
treatments result in an exponential increase of these 
resistance genes to a level where treatment failure 
occurs (Barnes et al., 1995; Sangster, 1999). The 
more intensively parasites are controlled with drugs, 
the more likely resistance will develop. Once resis-
tance is present in a parasite population, there is no 
evidence of reversion or loss of resistance (Sangster 
and Dobson, 2002). The dynamics of the selection 
for anthelmintic resistance of parasites in sheep have 
been well studied (Leathwick et al., 2009), and some 
predisposing factors are likely to be similar in the 
nematode parasites of cattle (Sutherland and Leath-
wick, 2011). These factors act either independently 
or in an additive fashion, and may be associated 
with the parasite species, the infected host, drug 
treatment, on-farm control management or the en-
vironment.
Parasite genetics and biology
Due to their genetic diversity, parasites in a popula-
tion do not respond uniformly to treatment. The high 
genetic diversity is linked to the huge population size 
and high reproduction rate of parasites (Vercruysse 
and Rew, 2002). It is presumed that resistance alleles 
already exist within the parasite population, prior to 
the fi rst introduction of a drug (Wolstenholme et al., 
2004). However, an alternative hypothesis suggests 
multiple origins of resistance by spontaneous and 
recurrent mutations (Skuce et al., 2010). Although 
the genetics of resistance are still poorly understood, 
resistance develops more quickly if only one gene 
is involved than when multiple genes are involved. 
Moreover, resistance develops faster if the genes are 
dominant rather than recessive: both heterozygote and 
homozygote worms will survive the treatment and 
contribute to the next generation (Sangster et al., 1998; 
Le Jambre et al., 2000; Coles, 2004). Furthermore, 
some parasites have biological characteristics that fa-
vor resistance alleles to build up faster in the popula-
tion, such as their direct life cycles (no intermediate 
host), a short generation time and high fecundity. It 
is assumed that, if resistant parasites have enhanced 
fi tness or if resistance is linked to other fi tness genes, 
the spread of resistance in the population will also 
increase. Fitness includes all properties that enable 
Region/country Number of % BZ % I/T % ML % Nematode species
and reference farms resistance  resistance resistance multidrug- involved
     resistance
New Zealand 62 76% ALB 6% LEV 92% IVM 74% ALB+IVM Cooperia spp. and 
(Waghorn et al., 2006)      Ostertagia spp.
Brazil 25 25% ALB 8% LEV 92% IVM 12% ALB+IVM Cooperia spp., 
(Soutello et al., 2007)    24% MOX  8% ALB+LEV+ Haemonchus spp. and
     IVM Oesophagostomum spp.
Argentina 25 32% FEN Not detected 60% IVM 28% FEN+IVM Cooperia spp. and 
(Suarez and Cristel, 2007)      Ostertagia spp.
Belgium, Germany
and Sweden 22 Not detected Not included 74% IVM Not detected Cooperia spp. and 
(Demeler et al., 2009)      Ostertagia spp.
Belgium and Germany 88 Not included Not included 39% IVM Not detected Cooperia spp.,
(El-Abdellati et al., 2010a)      Ostertagia spp.,
      Nematodirus spp. and
      Trichostrongylus axei
Table 2. Prevalence of the anthelmintic resistance of bovine nematodes. Resistance was considered if the fecal egg 
count reduction was below 90% (Brazil) or below 95%, with the lower confi dence interval lower than 90% (all other 
fi eld surveys). 
Abbreviations: % BZ, % I/T or % ML resistance: the percentage of farms with reduced anthelmintic effi cacy against benzimidazoles, 
imidothiazoles and tetrahydropyrimidines or macrocyclic lactones, respectively. ALB: albendazole; FEN: fenbendazole; LEV: levamisole; 
IVM: ivermectin; MOX: moxidectin.
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more worms to complete their life cycles, such as the 
egg-laying rate, the persistence of worms in the host (a 
reduced hypobiosis shortens their life cycles), survival 
on the pasture, the ability to migrate on herbage and 
their infectivity when ingested (Coles, 2005). It has 
also been suggested that ivermectin resistant Cooperia 
oncophora in cattle have become more pathogenic 
than susceptible worms (Coles et al., 2001; Wolsten-
holme et al., 2004).
Refugia and management factors
Refugium is the parasite population, which is not 
exposed to anthelmintic treatment. The larvae on pas-
ture, the percentage of animals left untreated and the 
arrested larval stages not affected by treatment of the 
host determine the parasites in refugia. The proportion 
of parasites in refugia needs to be optimal in order to 
dilute out the resistant genes in the pool of suscep-
tible genes. Hence, the development of anthelmintic 
resistance is delayed without causing clinical disease. 
The parasites in refugia, the frequency of anthelmintic 
treatment and the extent of underdosing are mainly 
responsible for inducing anthelmintic resistance (van 
Wyk, 2001). To decrease the selection pressure, it is of 
major importance that treatment and pasture manage-
ment are fulfi lled in ways that maintain refugia. An-
thelmintic treatments should progress according to a 
strategic plan, where frequency, time of treatment and 
the selective treatment of fi rst-year or infected animals 
are tightly followed. Short interval treatments that 
approach the prepatent period for the parasite, reduce 
the opportunities for susceptible worms to reproduce 
and diminish the parasites in refugia. On farms with 
an intensive breeding and/or grazing program, calves 
are given multiple treatments, and are grazed away 
from the adults. Hence, pasture contamination derives 
from worms surviving short interval treatments, which 
creates a selection pressure on anthelmintic resistance 
to develop (Kaminsky, 2003). Therefore, it is encour-
aged to implement an alternate grazing system, where 
calves are allowed to graze on pastures used by older 
animals the year before (Coles, 2005). It should also 
be avoided to treat animals and immediately moving 
them to a clean pasture. By doing so, contamination 
of the new pasture will only be attributed to a sub-
population that is resistant to treatment. In this respect, 
farmers should be aware that summer drought is a 
variable factor that clears out the free-living stages 
on pasture (Kaminsky, 2003). Additionally, bought-
in animals should be effectively quarantine drenched 
before they are placed on pasture in order to dilute out 
the progeny of survivors of the quarantine treatment 
(Pomroy, 2006).
Subtherapeutic drug levels
To ensure that treatments are fully effi cacious, it 
is important to weigh the animals fi rst, so that the 
anthelmintic drug can be given at the correct thera-
peutic dose level. Subtherapeutic concentrations allow 
more worms to survive the treatment, and increase 
the development rate of resistance. Reduced bioavail-
ability of the drug has been associated with the route 
of administration and the type of animal. Especially 
the inconsistent performance of topical (pour-on) 
applications has been questioned as a predisposing 
factor for resistance. Moreover, the enhanced drug 
metabolism of some types of animals or breeds, such 
as described in goats and in Belgian Blue cattle, may 
contribute to the selection for resistance (Vercruysse 
and Rew, 2002; Vercruysse et al., 2008). The selection 
pressure on the development of anthelmintic resistance 
is also affected by the pharmacokinetics of the drug. 
With the use of persistent (long-acting) or slow release 
drugs, the drug concentrations tail off slowly towards 
the end of their elimination phase as a result of an 
extended half-life. This effect has the same infl uence 
as underdosing animals. Therefore, short-acting drugs 
are preferably used (Bisset et al., 1990; Wolstenholme 
et al., 2004; Gonzalez Canga et al., 2009; El-Abdellati 
et al., 2010a; Sutherland and Leathwick, 2011).
THE IMPORTANCE OF DIAGNOSING AN-
THELMINTIC RESISTANCE
Regular drug treatments increase the selection 
pressure on the resistance alleles of the parasite popu-
lation. At a certain point, the anthelmintic drug is no 
longer useful in protecting the host against parasite in-
fections, and a change to another drug, with a different 
mode of action, is necessary. It is of great importance 
to detect anthelmintic resistance when the frequency 
of the resistance alleles of the parasite population is 
still low. In this way, the onset of anthelmintic resis-
tance may be delayed, and the effi cacy of the currently 
used anthelmintic drugs could be maintained (Martin 
et al., 1989).
The World Association for the Advancement of 
Veterinary Parasitology (WAAVP) has provided 
guidelines on the detection of anthelmintic resistance. 
However, in cattle, it is still diffi cult to assign the cor-
rect resistance status and to compare data of different 
surveys. The most accepted methods are two in vivo 
methods: the fecal egg count reduction test (FECRT) 
and the controlled effi cacy test (CET). Although the 
CET is the most reliable method, it is not feasible in 
commercial farm settings (Coles et al., 1992; Coles et 
al., 2006). In the following paragraphs the strengths 
and drawbacks of the available diagnostic tests for 
anthelmintic resistance are discussed.
Controlled effi cacy test
This in vivo test is suitable for all types of an-
thelmintic drugs, and is the gold standard for evalua-
ting their effi cacy. The CET requires the infected host 
to be sacrifi ced. Therefore, this test is not suitable 
for diagnosing resistance in the fi eld, but is ideal for 
dose-confi rmation studies or when the confi rmation of 
resistance is required. The percentage effi cacy is deter-
mined by comparing the means of surviving parasites 
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in groups of treated and untreated animals after artifi -
cial infection. Resistance is confi rmed when the reduc-
tion in worm counts is <90%, or when more than 1000 
worms survived the treatment (Taylor et al., 2002).
Fecal egg count reduction test
This in vivo procedure is currently the most practi-
cal method for the fi eld diagnosis of resistance against 
anthelmintic drugs. Based on the microscopic detec-
tion of nematode eggs in fecal samples of the infected 
host before and after treatment, the reduction in fecal 
egg counts (FECs) is calculated. At the moment, stan-
dards for the FECRT only exist for sheep. An accurate 
determination of resistance is more diffi cult in infected 
cattle than in infected small ruminants, since the FECs 
tend to be lower (Taylor et al., 2002). A population 
of worms is declared to be resistant if the percentage 
reduction is <95% and if the lower 95% confi dence 
interval is <90%. If only one of the two criteria is met, 
resistance is suspected (Coles et al., 1992).
The major limitation of the FECRT is its lack of 
analytic sensitivity. Martin et al. (1989) demonstrated 
that the FECRT only detects BZ-resistance in T. cir-
cumcincta and Trichostrongylus colubriformis in 
sheep when the frequency of the resistance alleles is 
greater than 25% in the parasite population. The modi-
fi ed McMaster technique, with a detection limit of 50 
eggs per gram feces (EPG), often fails to detect low 
numbers of eggs. As a consequence, an early diagno-
sis of resistance is impeded (Levecke et al., 2009). If 
pretreatment egg counts are <150 EPG, a more sen-
sitive counting method is recommended. Recently, 
the commercial FECPAK counting system has been 
introduced, and has a detection limit of 10 EPG to 
test for nematode egg counts in cattle (www.fecpak.
com). The FLOTAC technique, with a detection limit 
of 1-2 EPG, reaches the required sensitivity but loses 
on practicality (Cringoli, 2004). Another drawback of 
the FECRT is that it is not species-specifi c. In a mixed 
infection, it is impossible to differentiate microscopi-
cally the eggs of different nematode species. In order 
to calculate the species-specifi c drug effi cacies, it is 
suggested to culture fecal samples pre- and posttreat-
ment, from which third stage larvae can be harvested 
and differentiated. A third disadvantage is that the 
FECRT is labor intensive. Therefore, its use as a moni-
toring tool is limited.
The interpretation of the FECRT is affected by a 
complex interplay of various factors, including the 
detection limit of the FEC method, the number of 
animals per treatment group and the level of excre-
tion and aggregation of the FECs (Levecke et al., 
2012). Besides, the correlation between egg counts 
and worm numbers is not always clear, especially not 
in cattle (Eysker and Ploeger, 2000; Coles et al., 2006;
Kotze and Kopp, 2008). Due to the temporary sup-
pression of egg production caused by BZs and MLs, 
fecal samples should be collected 8-10 and 14-17 days 
after treatment with BZs or MLs, respectively (Coles 
et al., 2006). The variability of FECR data may also 
be attributed to the calculation methods (i.e. geometric 
means of FECs appear to overestimate the effi cacy 
compared to arithmetic FEC means) and the multiple 
formulas that are available (i.e. formulas may include/
exclude untreated control groups or may be based on 
individual FECs instead of group mean FECs) (Presi-
dente, 1985; Dash et al., 1988; Coles et al., 1992; 
Wood et al., 1995; Cabaret and Berrag, 2004; Dobson 
et al., 2009).
The outcome of the FECRT is also prone to con-
founding factors, which also apply to the CET. To 
reduce the likelihood of false positive results (reduced 
anthelmintic effi cacy without true anthelmintic resis-
tance), a number of requirements should be taken into 
account. Weighing the animals is essential to avoid a 
suboptimal treatment dosage. The pharmacokinetics 
of the drug vary according to the route of administra-
tion (bolus, topical, oral or injectable), formulation, 
body condition, age and physiological status. All of 
these factors contribute to differences in the (persis-
tent) activity of the anthelmintic, and may result in a 
lower drug effi cacy if the product is eliminated from 
the body of the host too fast (Lifschitz et al., 2004; 
Vercruysse et al., 2008; Gonzalez Canga et al., 2009).
To assess the (lack of) effi cacy of anthelmintic 
drugs that do not affect the parasite’s fecundity, ad-
ditional research is desired in order to optimize and 
validate the FECRT. The number of animals sampled 
and the detection limit of the test need to be better 
tailored to the level of infection and the aggregation 
of egg excretion (Levecke et al. 2012). The possibility 
to use pooled fecal samples should also be examined.
In vitro assays
In vitro assays have the advantages of low cost and 
having no inter-host variation, since no use of animals 
is required. Moreover, replication and standardization 
are possible (Sangster and Gill, 1999). Anthelmintic 
resistance can be detected by the following in vitro 
tests: larval migration inhibition assay (LMIA); micro-
motility meter test (MMT); larval development assay 
(LDA); larval feeding assay (LFA) and egg hatch as-
say (EHA).
Migration and motility tests are based on the drug-
induced paralysis of the body musculature of tricho-
strongyloid nematodes. In the LMIA, ex-sheathed 
third stage larvae (L3) are incubated in serial dilutions 
of anthelmintic for 24 hours, and subsequently trans-
ferred onto a sieve for a further 24 hours. Resistant L3 
are able to migrate through the sieve, while susceptible 
L3 remain on the mesh. Subsequently, the percentage 
migrated L3 is calculated. In the MMT, movements 
of L3 or adult worms, incubated in anthelmintic dilu-
tions, fractionate light rays, which are measured with 
a photodetector. The numerical representation of this 
signal is termed the motility index. Active worms give 
higher indices than paralyzed worms (Folz et al., 1987; 
Demeler et al., 2010).
The LDA measures the potency of the anthelmintic 
as inhibitor of the development, presumably as a result 
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of starvation through the inhibition of feeding. In case 
of the LDA, trichostrongyloid eggs are incubated for 
6-8 days in a growth medium with Escherichia coli 
as a food source and with the anthelmintic under test. 
Subsequently, the percentage developed L3 is calcu-
lated. Fresh eggs are the most crucial factor for the 
successful performance of the LDA (Gill et al., 1995; 
Demeler et al., 2010). A commercial LDA (Dren-
chrite®) has been developed for the detection of BZ- 
and levamisole resistance in sheep and goat nematodes 
(Tandon and Kaplan, 2004). ML-resistance may also 
be diagnosed with the LFA in which fi rst stage larvae 
(L1) are cultured with fl uorescein-5-isothiocyanate-
labelled E. coli and serial dilutions of the anthelmintic. 
Under a fl uorescence microscope, the ratio of fed and 
unfed larvae at each drug concentration is determined 
(Alvarez-Sanchez et al., 2005).
With the EHA, the proportion of eggs that (fail to) 
hatch in increasing drug concentrations is determined. 
Therefore, the EHA is only suitable for detecting BZ-
resistance, as MLs and I/Ts are not ovicidal. Eggs are 
fi rst recovered from the feces, then incubated in BZ-
dilutions for 48 h at 25°C, and subsequently stopped 
by adding one drop of Gram’s iodine. Finally, the 
eggs and larvae are microscopically counted. As for 
the LDA, fresh eggs are indispensable (von Samson-
Himmelstjerna et al., 2009a).
The results of in vitro tests are interpreted using 
EC50 values, describing the concentration at which a 
drug is half-maximal effective (50% of the parasites is 
killed). As by defi nition, resistant isolates have higher 
EC50 values than susceptible isolates. The biggest 
challenges for all of the diagnostic bioassays are the 
establishment of reference EC50 values and the deter-
mination of species-specifi c effi cacies in mixed para-
site infections. Therefore, the accuracy, sensitivity,
repeatability and reproducibility for different isolates 
and species in different laboratories still require opti-
mization. Additionally, validation against in vivo data 
is required, since the pharmacology of the drug in the 
host-parasite system is lost in in vitro assays (Sangster 
and Gill, 1999).
Molecular detection techniques
The sooner anthelmintic resistance is diagnosed, the 
better. Therefore, a promising alternative for the in vivo 
FECRT and CET and the in vitro assays could be a more 
sensitive molecular test, which could also overcome the
problem of egg suppression after treatment, for ex-
ample by analysing eggs before treatment. So far,
molecular markers for detecting and measuring
anthelmintic resistance only exist for BZs in sheep. 
Therefore, the WAAVP strongly encourages further 
investigation of the genetic mechanisms of resistance, 
especially in bovine nematodes.
Theoretically, molecular tests are capable of
detecting resistance alleles when the frequency of 
these alleles is still very low. Therefore, a genetic test 
for resistance requires the knowledge of the molecular 
basis of resistance. The identifi cation of mutations 
in target genes and the detection of alterations in the 
expression of genes could lead to the development of 
probes, respectively for pyrosequencing and real-time 
PCR. These techniques would enable the determina-
tion of susceptible or resistant populations (Ronaghi, 
2001; Gruber et al., 2002; Coles, 2005). As for in vivo 
and in vitro tests, the challenge still remains the correct 
identifi cation of resistance in mixed parasite infec-
tions. Furthermore, tests based on the detection of one 
single mutation to diagnose resistance make an under-
estimation if the resistance results from more than one 
underlying mechanism (Kwa et al., 1994; Coles, 2005; 
Coles et al., 2006; von Samson-Himmelstjerna et al., 
2009b). Once a molecular test is available, it remains 
to be determined at which resistance allele frequencies 
farmers will be recommended to stop using a drug. 
It can be asked whether or not it makes sense for a 
farmer to stop using a drug when a molecular test in-
dicates a low level of resistance, and the anthelmintic 
results in 95% reduction in egg counts (Kaplan and 
Vidyashankar, 2012).
ANTHELMINTIC RESISTANCE ON BELGIAN 
CATTLE FARMS
The predominant nematode species infecting cattle 
in temperate climate regions are O. ostertagi and C. 
oncophora, with 100% prevalence on pastures grazed 
by cattle. In Belgium, 72% of the farms use MLs to 
control parasite infections, of which 27% specifi cally 
use ivermectin (IVM) (Charlier et al., 2010). Cooperia 
spp. are considered to be the dose-limiting species 
for MLs. This means that the recommended dose is 
determined based on the effi cacy against these species 
(Vermunt et al., 1995; Vercruysse and Rew, 2002). 
The fi rst report of  reduced IVM effi cacy on Bel-
gian cattle farms dates from 2006 (Demeler et al., 
2009). At that time, seven farms were investigated, 
and on all of the seven farms, reduced effi cacies were 
observed 21 days after IVM treatment, with FEC re-
ductions ranging from 58-95%. After a revisit, the 
reduced IVM effi cacy could only be confi rmed on 
one farm, with a FEC reduction of 54% on day 21 
posttreatment. On all of the farms, only C. oncophora 
was recovered from the larval cultures. Continuous 
monitoring of the evolution of IVM-resistance dur-
ing four consecutive years on one of the previously 
investigated farms, showed a rapid increase of the 
resistance level in C. oncophora. After IVM treat-
ment, reductions in FECs of 73%, 40% and 0% were 
recorded, respectively in 2006, 2007 and 2008. One 
year later, side-resistance against moxidectin (MOX) 
was also determined (FECR of 83%), despite the fact 
that MOX had never been used on this farm before. 
This might suggest that the use of any type of MLs is 
inappropriate once IVM-resistance has been detected. 
On the other hand, fenbendazole, belonging to the BZ 
drug class, was still fully (100%) effective on this farm 
(El-Abdellati et al., 2010b). Recently, the CET has 
confi rmed the high resistance status of this particular 
C. oncophora fi eld isolate, with only a reduction of 
044994 VDT 3 2013.indd   118 13/06/13   16:35
Vlaams Diergeneeskundig Tijdschrift, 2013, 82 119
38% in worm burden after IVM treatment. Surpris-
ingly, the failure of MOX treatment was demonstrated 
even more clearly with only 31% reduction in worm 
counts, while the FECRT in this trial only suggested 
borderline resistance against MOX. The discrepancy 
between the FECs and worm counts for C. oncophora 
was explained by the reduced fecundity after MOX 
treatment. Failure of the FECRT to detect MOX re-
sistance has also been reported by other research-
ers (Yazwinski et al., 2013). As a consequence, the
FECRT is not a reliable assay to detect MOX resis-
tance, as some cases may be overlooked (De Graef et 
al., 2012; Yazwinski et al., 2013).
The rapid build-up of this resistant worm popula-
tion is impressive, and has given rise to a new survey 
on a larger number of farms, in order to make a better 
estimation of the prevalence of anthelmintic resistance 
in Belgium and Germany (Table 2). Of 88 farms in-
cluded in this study, 84 farms used MLs. A FECR 
<95% was observed on 33 out of the 84 farms (39%). 
Cooperia spp. were the most prevalent parasites after 
treatment, O. ostertagi, Nematodirius spp. and Tricho-
strongylus axei were also observed in small numbers 
(0.5-2.5%) on some of the farms using MLs. However, 
when taking into account the between-animal varia-
tion and measurement error, reduced effi cacy could 
only statistically be confi rmed on 25% of the farms. 
Moreover, when four farms were revisited, only on 
one farm, resistance against IVM could be confi rmed. 
These results showed that reduced effi cacy, observed 
with the FECRT, is not only caused by anthelmintic 
resistance, but that the detection limit of the FEC tech-
nique used and the (in)correct administration of the 
anthelmintic drugs are confounding factors of major 
importance (El-Abdellati et al., 2010a).
So far, emerging ML-resistance has only been re-
ported for C. oncophora and not for the more patho-
genic O. ostertagi on Belgian cattle farms. Since C. 
oncophora is the dose-limiting species for MLs, re-
sistance is expected to appear fi rst in this species. 
Moreover, Cooperia spp. are predominantly parasites 
of younger cattle, as immunity to Cooperia spp. tends 
to develop earlier than to for example O. ostertagi. 
Consequently, anthelmintic programs tailored to treat 
fi rst-year animals are likely to preferentially select for 
anthelmintic resistance in Cooperia spp. (Vercruysse 
and Claerebout, 1997; Sutherland and Leathwick, 
2011). On cattle farms in Sweden and Germany, ML-
resistance has been suspected in O. ostertagi, and is 
also expected to occur in Belgium. However, the exist-
ing levels of resistant O. ostertagi in Belgium are still 
below the detection threshold (Demeler et al., 2009).
HOW TO PREVENT ANTHELMINTIC RESIS-
TANCE?
Anthelmintic resistance mainly develops because 
of underdosing, frequent treatments and low refu-
gia. Dosing animals according to the manufacturer’s
recommendations is the fi rst requirement to reduce 
the development of anthelmintic resistance and to 
distinguish between treatment failure due to under-
dosing and true resistance. Secondly, farmers should 
integrate preventive anthelmintic treatments in their 
grazing management in order to reduce the number 
of treatments required. The main focus should be on 
the fi rst-grazing season calves, since they are most 
susceptible to gastrointestinal nematode infections. 
Complete eradication of gastrointestinal parasites on 
the pasture is not feasible. Instead, a low level of para-
sitism must be tolerated to trigger a protective immune 
response in the host, which will protect the animals 
in the following grazing seasons (Claerebout et al., 
1998). Measures that can be taken to reduce the larval 
pasture contamination and hence the number of treat-
ments include mowing, late turnout on pasture and 
reduced stocking density (Charlier et al., 2010). Serum 
pepsinogen levels can be determined at the end of the 
grazing season to evaluate the applied worm preven-
tion, which can then be optimized for the next batch 
of fi rst-grazing season calves, if necessary (Charlier et 
al., 2011). Recently, the importance of the worm popu-
lation in refugia for slowing down the development 
rate of anthelmintic resistance has been the focus of 
attention. This population is believed to be susceptible, 
and provides a reservoir in which resistant parasites 
may be diluted. Higher proportions of refugia may be 
achieved through a targeted selective treatment (TST) 
approach, where anthelmintic drugs are for example 
only administered to heavily infected individuals in 
the herd (Greer et al., 2009; Charlier et al., 2012). This 
strategy is based on the fact that the majority of the 
worms reside in the minority of the animals (Stafford 
et al., 2009). For the successful implementation of the 
TST approach, it is essential to identify those animals 
with the highest worm burdens. Today, most cattle 
farmers apply a TST strategy but only to administer 
additional treatments during summer to animals that 
show signs of clinical PGE. However, a preventive 
TST approach should preferably be pursued. Unfor-
tunately, for cattle, there are no convenient diagnos-
tics to identify the animals in the herd that should be 
treated. FECs can be determined two months after the 
turnout, or the weight gain per animal can be moni-
tored, but both approaches are too labor-intensive to 
be widely used (Hoglund et al., 2009). It would be 
interesting if a sensitive molecular test could be inte-
grated in a TST approach, in order to identify the most 
heavily infected animals and simultaneously defi ne the 
resistance status of the parasites.
Another advice farmers could take into account 
to reduce the development rate of anthelmintic resis-
tance, is avoiding the use of the same class of anthel-
mintic drugs every year. In this way, the effi cacy will 
be maximized and the longevity of the compounds 
will be prolonged (Dobson et al., 2001). Recently, 
the WAAVP guidelines have requested the approval 
of anthelmintic combination products for the use in 
ruminant livestock and in horses (Geary et al., 2012). 
The use of combination products may maximize the 
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breadth of spectrum, may overcome species-specifi c 
resistance profi les (dose-limiting species), and may 
delay the development and spread of resistance when 
the resistance allele frequencies are still low. More-
over, research on several alternative measures that 
reduce the dependence on anthelmintic drugs is also 
ongoing. For example, nematophagous microfungi, 
such as Duddingtonia fl agrans, could be given in an 
oral formulation. After passage through the bovine 
gastrointestinal tract, they reduce pasture contamina-
tion by preying on the pasture larvae (Waller et al., 
1994; Assis et al., 2012). Additionally, immunologic 
control of worm infections through vaccination could 
be the answer to anthelmintic resistance. However, de-
spite the identifi cation of several candidate protective 
antigens, no vaccines against gastrointestinal nema-
tode parasites are currently available (Claerebout et 
al., 2003; Vercruysse et al., 2007).
CONSIDERATIONS
Most Belgian farmers are unaware of the anthel-
mintic resistance status on their farms, mainly because 
they have not encountered any problems yet. How-
ever, it is important to be forethoughtful. In sheep 
nematodes, it has been demonstrated that once the fre-
quencies of resistance alleles exceed a certain thresh-
old, these frequencies will exponentially increase. 
From this stage, the used anthelmintic drugs is no 
longer effi cacious. Although it is not known how fast 
the resistance to a certain anthelmintic drug devel-
ops, it is irreversible, and alternatives are scarce. Until
better diagnostics are available, it remains important 
to routinely monitor the effi cacy of anthelmintic drugs 
at farm level with the FECRT. Although the FECRT is 
not sensitive enough to detect resistance in the initial 
phase, it can detect resistance before clinical treatment 
failure occurs, which is the current ‘detection thres-
hold’ for most farmers.
When reduced anthelmintic effi cacy is confi rmed to 
be ML-resistance by the FECRT, farmers are advised 
to change to an anthelmintic drug class with a different 
mode of action. Unfortunately, only few anthelmintic 
classes with a different mode of action are currently 
available as alternatives for MLs, i.e. benzimidazoles 
and imidazothiazoles. Recently, antiparasitic com-
pounds with a novel mode of action, i.e. monepantel 
and derquantel (Table 1), have been introduced on 
the market, but until now, both products have only 
been registered for the use in sheep. When alternative 
drugs are advised in cases of ML-resistance, these 
anthelmintic drugs should also be used with caution in 
order to prevent the development of resistance against 
this drug class. Furthermore, it should be stressed that 
any adjustments of worm control programs are case-
specifi c, since they depend on the treatment history 
and the pasture management of the farm. Decision 
support systems (based on computer simulations) can 
make it easier to improve future decision making on 
nematode control at farm level (Greer et al., 2009; 
Charlier et al., 2012).
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